Locarnini S - Search Results

1

A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.

Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM. Lim SG, et al. Among authors: locarnini s. Antivir Ther. 2006;11(2):245-53. Antivir Ther. 2006. PMID: 16640105 Clinical Trial.

2

Hepatitis B surface antigen quantification: not what it seems on the surface.

Locarnini S, Bowden S. Locarnini S, et al. Hepatology. 2012 Aug;56(2):411-4. doi: 10.1002/hep.25732. Epub 2012 Jul 6. Hepatology. 2012. PMID: 22454331 No abstract available.

3

Drug resistance in antiviral therapy.

Locarnini S, Bowden S. Locarnini S, et al. Clin Liver Dis. 2010 Aug;14(3):439-59. doi: 10.1016/j.cld.2010.05.004. Clin Liver Dis. 2010. PMID: 20638024 Review.

4

Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion.

Cheng Y, Guindon S, Rodrigo A, Wee LY, Inoue M, Thompson AJ, Locarnini S, Lim SG. Cheng Y, et al. Among authors: locarnini s. Gut. 2013 Sep;62(9):1347-55. doi: 10.1136/gutjnl-2012-302408. Epub 2012 Dec 15. Gut. 2013. PMID: 23242209

5

Rescue therapy for drug resistant hepatitis B: another argument for combination chemotherapy?

Shaw T, Bowden S, Locarnini S. Shaw T, et al. Among authors: locarnini s. Gastroenterology. 2004 Jan;126(1):343-7. doi: 10.1053/j.gastro.2003.11.022. Gastroenterology. 2004. PMID: 14699512 Review. No abstract available.

6

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.

Sung JJ, Wong ML, Bowden S, Liew CT, Hui AY, Wong VW, Leung NW, Locarnini S, Chan HL. Sung JJ, et al. Among authors: locarnini s. Gastroenterology. 2005 Jun;128(7):1890-7. doi: 10.1053/j.gastro.2005.03.009. Gastroenterology. 2005. PMID: 15940624 Clinical Trial.

7

Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients.

Lesmana CR, Jackson K, Lim SG, Sulaiman A, Pakasi LS, Gani RA, Hasan I, Sulaiman AS, Lesmana LA, Hammond R, Revill P, Locarnini S, Bowden SD. Lesmana CR, et al. Among authors: locarnini s. United European Gastroenterol J. 2014 Apr;2(2):99-107. doi: 10.1177/2050640614525151. United European Gastroenterol J. 2014. PMID: 24918014 Free PMC article.

8

Chemotherapy for hepatitis B: new treatment options necessitate reappraisal of traditional endpoints.

Shaw T, Bowden S, Locarnini S. Shaw T, et al. Among authors: locarnini s. Gastroenterology. 2002 Dec;123(6):2135-40. doi: 10.1053/gast.2002.37288. Gastroenterology. 2002. PMID: 12454868 Review. No abstract available.

9

96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B.

Hui CK, Zhang HY, Bowden S, Locarnini S, Luk JM, Leung KW, Yueng YH, Wong A, Rousseau F, Yuen KY, Naoumov NN, Lau GK. Hui CK, et al. Among authors: locarnini s. J Hepatol. 2008 May;48(5):714-20. doi: 10.1016/j.jhep.2007.10.013. Epub 2007 Dec 31. J Hepatol. 2008. PMID: 18207280 Clinical Trial.

10

Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.

Sievert W, Pianko S, Warner S, Bowden S, Simpson I, Bowden D, Locarnini S. Sievert W, et al. Among authors: locarnini s. Am J Gastroenterol. 2002 Apr;97(4):982-7. doi: 10.1111/j.1572-0241.2002.05550.x. Am J Gastroenterol. 2002. PMID: 12003436

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page